The Department of Health and Human Services late Thursday announced that Gilead, the drug company behind the pre-exposure prophylaxis (PrEP) medication medication Truvada, would provide PrEP for up to 200,000 individuals each year for up to 11 years. The Department of Health and Human Services late Thursday announced that Gilead, the drug company behind the … Continue reading HHS Announces Deal with Gilead to Provide PrEP to 200,000 People for 11 Years